Arrayit Corporation has leveraged its proprietary life sciences platform to develop OvaDx®, the first definitive diagnostic screening test for early stage detection of ovarian cancer. Arrayit also has pipeline diagnostic tests for Parkinson’s Disease, Plavix®, Male Fertility, and Prostate Cancer. These microarray-based tests will be available to the public upon FDA approval.
Copyright 1993-2014 Arrayit Corporation. All rights reserved.